Outcomes of EGFR, ALK, ROS1, BRAF, MET, and RET mutated non-small cell lung cancer with brain metastases (NSCLC BM).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Xiaoyan Li, Weiwei Shi
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401514781
